Revolution Medicines (RVMD) Prepaid Assets (2019 - 2026)
Revolution Medicines (RVMD) recorded quarterly Prepaid Assets of $59.8 million in Q1 2026, up 21.21% quarter-over-quarter from $49.4 million in Q4 2025, and up 87.51% on a YoY basis from $31.9 million in Q1 2025.
Revolution Medicines (RVMD) Prepaid Assets (2019 - 2026) Analysis & Trends
Revolution Medicines' Prepaid Assets history runs 8 years deep, the most recent figure standing at $59.8 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 87.51% year-over-year to $59.8 million; the TTM figure through Mar 2026 stood at $59.8 million (up 87.51% YoY), while the FY2025 annual figure was $49.4 million, up 28.76% from the prior year.
- Prepaid Assets was $59.8 million for Q1 2026 at Revolution Medicines, up from $49.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $59.8 million in Q1 2026 to a low of $9.0 million in Q1 2023.
- Historically, Prepaid Assets has averaged $27.1 million across 5 years, with a median of $25.7 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets sank 36.88% in 2023, then surged 237.02% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $10.6 million in 2022, then jumped by 137.22% to $25.1 million in 2023, then soared by 52.89% to $38.3 million in 2024, then climbed by 28.76% to $49.4 million in 2025, then advanced by 21.21% to $59.8 million in 2026.
- The last three Prepaid Assets figures came in at $59.8 million (Q1 2026), $49.4 million (Q4 2025), and $46.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Revolution Medicines | 32.33 Bn | 32.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.83 Mn |
| Dec 31, 2025 | 49.36 Mn |
| Sep 30, 2025 | 45.98 Mn |
| Jun 30, 2025 | 39.27 Mn |
| Mar 31, 2025 | 31.91 Mn |
| Dec 31, 2024 | 38.33 Mn |
| Sep 30, 2024 | 29.66 Mn |
| Jun 30, 2024 | 34.02 Mn |
| Mar 31, 2024 | 25.66 Mn |
| Dec 31, 2023 | 25.07 Mn |
| Sep 30, 2023 | 10.96 Mn |
| Jun 30, 2023 | 10.09 Mn |
| Mar 31, 2023 | 8.96 Mn |
| Dec 31, 2022 | 10.57 Mn |
| Sep 30, 2022 | 15.16 Mn |
| Jun 30, 2022 | 15.99 Mn |
| Mar 31, 2022 | 10.21 Mn |
| Dec 31, 2021 | 6.79 Mn |
| Sep 30, 2021 | 7.47 Mn |
| Jun 30, 2021 | 8.16 Mn |